BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2024 2:44:49 PM | Browse: 58 | Download: 78
 |
Received |
|
2023-10-20 13:03 |
|
Peer-Review Started |
|
2023-10-20 13:05 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-11-21 08:15 |
|
Revised |
|
2023-12-27 17:43 |
|
Second Decision |
|
2024-01-24 02:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-01-24 08:19 |
|
Articles in Press |
|
2024-01-24 08:19 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-01-23 18:32 |
|
Typeset the Manuscript |
|
2024-02-07 08:01 |
|
Publish the Manuscript Online |
|
2024-03-11 14:44 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nayana Sudevan, Manish Manrai, T V S V G K Tilak, Harshit Khurana and Harikrishnan Premdeep |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Manish Manrai, FRCPE, MBBS, MD, Professor, Department of Gastroenterology, Command Hospital, Lucknow, Sadar Bazaar, Cantonment, Lucknow 226002, India. manishmanrai75@yahoo.com |
| Key Words |
Hepatitis B virus; Chronic hepatitis B; Occult B infection; Oncology; Hepatitis B reactivation; Hematology-oncology |
| Core Tip |
Hepatitis B virus (HBV) reactivation, a significant risk for individuals undergoing immunosuppressive therapy such as cancer chemotherapy, can lead to preventable morbidity and mortality. Our observational study determined the prevalence of chronic HBV (CHB) infection and occult HBV infection (OBI) in oncology and hematology-oncology patients receiving chemotherapy. Our results showed a 2.3% prevalence of CHB and 0.8% prevalence of OBI in our study cohort, underscoring the critical importance of routinely screening oncology and hematology-oncology patients for HBV infection. Identifying those with CHB and OBI is vital for promptly initiating antiviral prophylaxis, which can prevent the reactivation of HBV infection. |
| Publish Date |
2024-03-11 14:44 |
| Citation |
Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104 |
| URL |
https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v13.i1.89104 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
